NCT01605981 Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase. Status WITHDRAWN Phase PHASE4
NCT01604278 Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01602835 Human Urine Sample Collection for Alport Nephropathy Biomarker Studies Status TERMINATED Phase N/A
NCT01602406 Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer Status COMPLETED Phase PHASE1
NCT01602315 A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT01601600 A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults Status COMPLETED Phase PHASE2
NCT01601470 Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension Status COMPLETED Phase PHASE2
NCT01599650 Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion Status COMPLETED Phase PHASE3
NCT01599637 Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment Status COMPLETED Phase PHASE2
NCT01599104 Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension Status COMPLETED Phase PHASE3
NCT01598987 Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients. Status COMPLETED Phase PHASE3
NCT01598103 Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions Status TERMINATED Phase PHASE2
NCT01598077 A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer Status COMPLETED Phase PHASE1
NCT01597908 Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma Status COMPLETED Phase PHASE3
NCT01596712 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects Status COMPLETED Phase PHASE1
NCT01596647 Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01596062 Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) Status COMPLETED Phase PHASE2
NCT01595009 An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1) Status COMPLETED Phase PHASE4
NCT01594983 A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia Status COMPLETED Phase PHASE2
NCT01594957 Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment Status COMPLETED Phase PHASE1